Chronic Hepatitis C Therapy in Liver Cirrhosis Complicated by Telaprevir-Induced DRESS

Chronic Hepatitis C Therapy in Liver Cirrhosis Complicated by Telaprevir-Induced DRESS

Drug reaction with eosinophilia and systemic symptoms (DRESS) is a rare yet severe adverse drug-induced reaction with up to 10% mortality rate. Recent clinical trials reported an association between DRESS and telaprevir (TVR), an NS3/4A protease inhibitor of chronic hepatitis C (CHC) virus genotype...

Full description

Bibliographic Details
Main Authors:	Omar Y. S. Mousa, Rossa Khalaf, Rhonda L. Shannon, Chukwuma I. Egwim, Scott A. Zela, Victor Ankoma-Sey
Format:	Article
Language:	English
Published:	Hindawi Limited 2014-01-01
Series:	Case Reports in Medicine
Online Access:	http://dx.doi.org/10.1155/2014/380424

Similar Items

Review of Boceprevir and Telaprevir for the Treatment of Chronic Hepatitis C
by: Kyle J Wilby, et al.
Published: (2012-01-01)

Telaprevir: Changing the standard of care of chronic hepatitis C
by: A K Rajani, et al.
Published: (2013-01-01)

Hepatitis C in Brazil: lessons learned with boceprevir and telaprevir
by: Lenyta Oliveira Gomes, et al.
Published: (2018-06-01)

NUTRITIVE THERAPY OF HEPATIC ENCEPHALOPATHY AS A COMPLICATION OF LIVER CIRRHOSIS
by: Bojana Marković-Živković, et al.
Published: (2012-06-01)

Liver Apparent Diffusion Coefficient Changes during Telaprevir-Based Therapy for Chronic Hepatitis C
by: Nagihan İnan Gürcan, et al.
Published: (2016-12-01)

Final Results of the Telaprevir Access Program: FibroScan Values Predict Safety and Efficacy in Hepatitis C Patients with Advanced Fibrosis or Cirrhosis.
by: Antonia Lepida, et al.
Published: (2015-01-01)

Boceprevir and telaprevir utilization evaluation for the treatment of chronic hepatitis C
by: P. Marrero-Álvarez, et al.
Published: (2014-01-01)

Cost-effectiveness of Telaprevir combination therapy for chronic hepatitis C.
by: Anita J Brogan, et al.
Published: (2014-01-01)

The use of telaprevir for the treatment of hepatitis C in patients undergoing liver transplantation (Literature review and clinical experience)
by: M. Sh. Khubutiya, et al.
Published: (2016-02-01)

Efficacy of telaprevir-based therapy in stable liver transplant patients with chronic genotype 1 hepatitis C
by: Xavier Forns, et al.
Published: (2016-07-01)

Feasibility of telaprevir-based triple therapy in liver transplant patients with hepatitis C virus: SVR 24 results.
by: Christoph R Werner, et al.
Published: (2013-01-01)

Antimitochondrial antibody serocoversion post-liver transplant during hepatitis C treatment with peginterferon α, ribavirin and telaprevir
by: Vladimir Marquez-Azalgara, et al.
Published: (2014-09-01)

Clinical features of male patients with alcoholic liver cirrhosis or hepatitis B cirrhosis complicated by abnormal glucose metabolism
by: CHEN Qidan, et al.
Published: (2016-02-01)

Telaprevir: New possibilities for antiviral treatment in patients with chronic hepatitis C
by: I G Nikitin, et al.
Published: (2012-11-01)

Telaprevir or Boceprevir for Hepatitis C treatment: a first survey of pharmacoutilization
by: Maurizio eCapuozzo, et al.
Published: (2013-09-01)

Retreatment of Chronic Hepatitis C Infection with Telaprevir: Preliminary Results in Turkey
by: Orhan Yıldız, et al.
Published: (2015-09-01)

Hepatic adenomatosis in liver cirrhosis
by: Sonja Gordic, et al.
Published: (2017-01-01)

Haemophagocytic syndrome in a liver transplant patient during treatment with Telaprevir
by: Beatriz Rodríguez-Medina, et al.
Published: (2013-11-01)

Hepatosplenic Sarcoidosis Complicated by Liver Cirrhosis
by: Benjamin Peters, et al.
Published: (2015-12-01)

Cutaneous Eruption due to Telaprevir
by: Eduardo Mastrangelo Marinho Falcão, et al.
Published: (2015-09-01)

KASL clinical practice guidelines for liver cirrhosis: Varices, hepatic encephalopathy, and related complications
Published: (2020-04-01)

Pulmonary sarcoidosis in the context of a telaprevir-based triple therapy for hepatitis C
by: D. Pérez Parente, et al.
Published: (2016-01-01)

Rhabdomyolysis in a hepatitis C virus infected patient treated with telaprevir and simvastatin
by: Clara T.M.M. de Kanter, et al.
Published: (2014-07-01)

Triple antiviral therapy with telaprevir after liver transplantation: a case series
by: Knapstein J, et al.
Published: (2014-09-01)

Usefulness of Carnitine Supplementation for the Complications of Liver Cirrhosis
by: Tatsunori Hanai, et al.
Published: (2020-06-01)

Research advances in liver cirrhosis complicated by bacteremia
by: WANG Jingyun
Published: (2014-07-01)

Treatment of experienced and na&iuml;ve patients with hepatitis C: focus on telaprevir
by: D&#39;Ambrosio R, et al.
Published: (2012-10-01)

Cost-effectiveness of Triple Therapy with Telaprevir for Chronic Hepatitis C Virus Patients in Germany
by: Jona T. Stahmeyer, et al.

Hepatitis C genotype 1b and 4 cured after telaprevir-based therapy
by: Diego Pérez-Parente, et al.
Published: (2015-04-01)

Evaluation of factors associated with relapse in telaprevir-based triple therapy for chronic hepatitis C
by: C Kondo, et al.
Published: (2016-01-01)

Cost-utility analysis of triple therapy with telaprevir in treatment-naïve hepatitis C patients
by: Blanca Gros, et al.
Published: (2014-09-01)

Budget impact analysis of boceprevir and telaprevir for the treatment of hepatitis C genotype 1 infection
by: El Khoury AC, et al.
Published: (2012-11-01)

Mycobacterium abscessus pulmonary infection during hepatitis C treatment with telaprevir, peginterferon and ribavirin
by: Alejandro Soza, M.D., et al.
Published: (2015-01-01)

Telaprevir-containing regimen for treatment of hepatitis C virus infection in patients with hepatocellular carcinoma awaiting liver transplantation: a case series
by: Torres HA, et al.
Published: (2014-07-01)

Multicenter Experience with Boceprevir or Telaprevir to Treat Hepatitis C Recurrence after Liver Transplantation: When Present Becomes Past, What Lessons for Future?
by: Audrey Coilly, et al.
Published: (2015-01-01)

One case of hepatitis B cirrhosis complicated by rhabdomyolysis
by: ZHANG Dali
Published: (2015-03-01)

A case of post-hepatitis B cirrhosis complicated by hepatic myelopathy
by: GUO Fengchang, et al.
Published: (2017-09-01)

Treatment of Hepatitis B in Decompensated Liver Cirrhosis
by: Richard Guan, et al.
Published: (2011-01-01)

Chronic hepatitis C successfully treated with telaprevir, pegylated interferon and ribavirin in severe aplastic anemia
by: Ilker I. Balkan, et al.
Published: (2014-11-01)

Effects on anemia of drug adjustment in patients with chronic hepatitis C during telaprevir-combined therapy
by: Akihiro Tamori, et al.
Published: (2015-01-01)